Avaleht › Difuusne suure B-raku lümfoom › Pennsylvania › Philadelphia
Difuusne suure B-raku lümfoom kliinilised uuringud linnas Philadelphia, PA
15 uuringut haiguse Difuusne suure B-raku lümfoom jaoks otsivad osalejaid linnas Philadelphia ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
VärbamineFaas 2
- Fox Chase Cancer Center, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
VärbamineVaatlusuuring
- Children's Hospital of Philadelphia, Philadelphia
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
VärbamineFaas 2
- Thomas Jefferson University Hospital, Philadelphia
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
VärbamineFaas 2/3
- Alliance Cancer Specialists (ACS) ( Site 8001), Horsham · 16 mi kaugusel
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
VärbamineFaas 2
- Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131), Philadelphia
- Temple University Hospital ( Site 0133), Philadelphia
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
VärbamineFaas 1
- University of Pennsylvania Abramson Cancer Center, Philadelphia
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
VärbamineFaas 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
VärbamineFaas 1/2
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
VärbamineFaas 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
VärbamineFaas 1
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
VärbamineFaas 1
- Abramson Cancer Center, University of Pennsylvania, Philadelphia
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
VärbamineFaas 2
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia
SynKIR-310 for Relapsed/Refractory B-NHL
VärbamineFaas 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
VärbamineFaas 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Difuusne suure B-raku lümfoom uuringud teistes linnades
- New York City, NY21 uuringut
- Baldwin Park, CA19 uuringut
- Chicago, IL18 uuringut
- Houston, TX17 uuringut
- Los Angeles, CA17 uuringut
- Boston, MA16 uuringut
- Milwaukee, WI16 uuringut
- Nashville, TN15 uuringut
- Portland, OR15 uuringut
- Durham, NC14 uuringut
- Dallas, TX13 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Philadelphia
- Vähk (kõik liigid)59 uuringut
- Rinnavähk56 uuringut
- Mitteväikerakuline kopsuvähk51 uuringut
- Metastaatiline vähk46 uuringut
- Käär- ja pärasoolevähk44 uuringut
- Munasarjavähk44 uuringut
- Eesnäärmevähk44 uuringut
- Kopsuvähk36 uuringut
- Äge müeloidne leukeemia34 uuringut
- Südamepuudulikkus31 uuringut
- Endomeetriumivähk28 uuringut
- Depressioon26 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.